-
2024-519620-24-01
5
2026-06-01
ANCA-associated vasculitis
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2025-521889-95-00
6
2026-05-04
Crohn's Disease
-
2025-523690-41-00
5
2026-05-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-509891-40-00
5
2026-04-28
Pulmonary arterial hypertension
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2023-507801-32-00
6
2026-04-22
Isolated Subsegmental Pulmonary Embolism
-
2024-520014-22-00
5
2026-04-22
Locally advanced/metastatic urothelial carcinoma
-
2024-520205-39-00
5
2026-04-21
Traumatic brain injury
-
2024-517674-23-00
5
2026-04-09
Subjects undergoing elective endovascular coiling-only repair of unrup
-
2025-523263-37-00
10
2026-04-08
Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal
-
2024-516639-28-00
5
2026-03-27
norepinephrine-refractory vasoplegic shock
-
2024-516643-64-00
5
2026-03-13
Aortic bioprothesis implanted patient for valvular heart disease
-
2023-506291-28-00
5
2026-03-02
Patient with locally advanced/metastatic, MSI-H/dMMR gastric cancer
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer
-
2025-522640-41-00
4
2026-02-13
Asthma
-
2025-522914-22-00
3
2026-02-11
Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)
-
2025-520638-53-00
5
2026-02-09
Severe primary dysmenorrhea
-
2024-519505-35-00
5
2026-02-02
hepatocellulaR carcinoma
-
2024-519369-24-00
5
2026-01-29
METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
-
2025-522400-24-00
10
2026-01-27
Metastatic urothelial cancer
-
2024-515023-11-00
5
2026-01-22
Metastatic Clear Cell Renal Cell Carcinoma
-
2024-516471-33-00
4
2026-01-19
Alport Syndrome